These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28699810)
1. A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells. Jiang C; Ding Z; Joy M; Chakraborty S; Kim SH; Bottcher R; Condeelis J; Singh S; Roy P Cell Cycle; 2017; 16(24):2366-2373. PubMed ID: 28699810 [TBL] [Abstract][Full Text] [Related]
2. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells. Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810 [TBL] [Abstract][Full Text] [Related]
3. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314 [TBL] [Abstract][Full Text] [Related]
4. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. Das T; Bae YH; Wells A; Roy P J Cell Physiol; 2009 Feb; 218(2):436-43. PubMed ID: 18937284 [TBL] [Abstract][Full Text] [Related]
5. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506 [TBL] [Abstract][Full Text] [Related]
6. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. Bae YH; Ding Z; Zou L; Wells A; Gertler F; Roy P J Cell Physiol; 2009 May; 219(2):354-64. PubMed ID: 19115233 [TBL] [Abstract][Full Text] [Related]
7. Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation. Jiang C; Veon W; Li H; Hallows KR; Roy P Cell Cycle; 2015; 14(18):2914-23. PubMed ID: 26176334 [TBL] [Abstract][Full Text] [Related]
8. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. Zou L; Ding Z; Roy P J Cell Physiol; 2010 Jun; 223(3):623-9. PubMed ID: 20143334 [TBL] [Abstract][Full Text] [Related]
9. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses. Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514 [TBL] [Abstract][Full Text] [Related]
10. Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis. Yao W; Ji S; Qin Y; Yang J; Xu J; Zhang B; Xu W; Liu J; Shi S; Liu L; Liu C; Long J; Ni Q; Li M; Yu X Mol Cancer; 2014 Aug; 13():187. PubMed ID: 25103363 [TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction. Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288 [TBL] [Abstract][Full Text] [Related]
12. Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells. Chakraborty S; Jiang C; Gau D; Oddo M; Ding Z; Vollmer L; Joy M; Schiemann W; Stolz DB; Vogt A; Ghosh S; Roy P Br J Cancer; 2018 Oct; 119(9):1106-1117. PubMed ID: 30318519 [TBL] [Abstract][Full Text] [Related]
13. Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner. Zou L; Hazan R; Roy P Cell Motil Cytoskeleton; 2009 Dec; 66(12):1048-56. PubMed ID: 19593789 [TBL] [Abstract][Full Text] [Related]
14. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization. Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495 [TBL] [Abstract][Full Text] [Related]
15. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models. Frantzi M; Klimou Z; Makridakis M; Zoidakis J; Latosinska A; Borràs DM; Janssen B; Giannopoulou I; Lygirou V; Lazaris AC; Anagnou NP; Mischak H; Roubelakis MG; Vlahou A Oncotarget; 2016 Oct; 7(43):70750-70768. PubMed ID: 27683119 [TBL] [Abstract][Full Text] [Related]
16. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation. Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138 [TBL] [Abstract][Full Text] [Related]
17. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S; Vomhof-DeKrey E; Basson MD Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790 [TBL] [Abstract][Full Text] [Related]
18. C-Terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration. Choi YN; Lee SK; Seo TW; Lee JS; Yoo SJ Biochem Biophys Res Commun; 2014 Apr; 446(4):1060-6. PubMed ID: 24661873 [TBL] [Abstract][Full Text] [Related]
19. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Wu N; Zhang W; Yang Y; Liang YL; Wang LY; Jin JW; Cai XM; Zha XL Proteomics; 2006 Nov; 6(22):6095-106. PubMed ID: 17051635 [TBL] [Abstract][Full Text] [Related]
20. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts. Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]